Instituto Butantan responsible for developing the vaccine and conducting trials in the country, announced last week the vaccine had a 78% overall efficacy
Trials in Brazil show the Chinese COVID-19 vaccine Sinovac to be 50.38% effective, nearly 30 percentage points below the initial results released last week. The Instituto Butantan, the São Paulo-based research institute responsible for developing the vaccine and conducting trials in the country, announced last week the vaccine had a 78% overall efficacy, with total protection against severe cases.
The new trials, which involved 12,508 volunteers, have shown that Sinovac continues to be 100% effective in blocking severe cases.
“This is an efficient vaccine,” Instituto Butantan Chief Researcher Ricardo Palacios said during a press conference on Tuesday. “We have a vaccine that is able to control the pandemic through this expected effect, which is the decrease in the disease’s intensity.”
To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.
By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal.
You can withdraw your consent using the method specified in the Privacy Policy.
Accept & Close
Sputnik International
Brazil has signed an agreement with the Butantan Institute of Sao Paulo to purchase 100 million doses of CoronaVac COVID-19 vaccines, developed by Chinese company Sinovac, Brazilian Health Minister Eduardo Pazuello said on Thursday.
To print this article, all you need is to be registered or login on Mondaq.com.
The Brazilian National Health Surveillance Agency (Anvisa)
approved on October 7, 2020, new labeling rules regarding packaged
food s nutrition labeling. The measure improves the clarity and
legibility of the nutritional information on labels and helps
consumers to make informed choices. The new rules - contained in
Normative Instruction No. 75, and the Resolution of the Collegiate
Board No. 429, both published on October 8, 2020 - will come into
force on October 2022.
The most relevant change is the creation of a front nutrition
label informing about high content of added sugar, saturated fats